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Abstract
Background: The community pharmacy center of the Department of Ambulatory Care and Community Medicine
of the Policlinique Médicale Universitaire (PMU), Lausanne, Switzerland developed and implemented an
interprofessional medication adherence program for chronic patients (IMAP). In 2014, a project was launched
to implement the IMAP for HIV patients in a public non-academic hospital with the collaboration of community
pharmacists in the Neuchâtel area (Switzerland). This article aims to describe the different implementation stages and
strategies of the project.
Methods: A posteriori description of the implementation process, including the conceptualization strategies and
stages (exploration, preparation, operation, sustainability) using the Framework for the Implementation of Services in
Pharmacy (FISpH).
Results: In 2014, an attending infectious disease physician and a nurse at a public hospital (Neuchâtel, Switzerland)
contacted the PMU to implement the IMAP in their setting in collaboration with community pharmacies. Five
volunteer community pharmacies in Neuchâtel were trained to deliver the program. Three factors were found
to be essential to the successful launch and progress of the implementation project: the experience of the
community pharmacy center of the PMU with the IMAP, the involvement of the PMU research team, and
collaboration with an external start up (SISPha) to train and support pharmacists. During the operation stage,
the most important strategy developed was that of regular meetings between all stakeholders. These allowed
healthcare professionals to discuss the implementation progress, to address each stakeholder’s expectations,
and to exchange experiences to facilitate interprofessional collaboration and program delivery. Structural changes
allowed the formalization of the activities at the hospital and in a community pharmacy. This formalization was
identified as the transition step between the operation and the sustainability stages.
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Conclusions: The transfer of the IMAP for HIV patients to a non-academic setting and its implementation are
feasible. However, implementation of a new model of pharmacy service such as IMAP implies a deep change
in practice. A transitional external support and the allocation of sufficient resources to carry out the IMAP are
essential for its long-term sustainability.
Keywords: Implementation process, Implementation strategies, FISpH, Medication adherence, IMAP, Community
pharmacy service, Interprofessionality, HIV patients
Background
An innovative interprofessional medication adherence
program (IMAP) was developed and implemented in the
community pharmacy center of the Department of
Ambulatory Care and Community Medicine at the
Policlinique Médicale Universitaire (PMU), Lausanne,
Switzerland [1]. In 2004, the program was developed in
collaboration with the infectious diseases service of the
University hospital (CHUV, Lausanne, Switzerland) and
focused on HIV-positive patients. In Switzerland, around
20′000 persons live with HIV [2]. In the context of a
transmitted disease with potential development of treat-
ment resistances, support of adherence to antiretroviral
treatments takes on its full meaning. Initially, this program
was confined to the community pharmacy of the PMU. In
2008, its research team attempted to implement its medi-
cation adherence program for hypertensive, diabetic and/
or dyslipidemic patients in community pharmacies in the
French-speaking part of Switzerland [3]. The study failed
and detected four major barriers to implementation: a)
lack of pharmacist-patient communication, which led to
insufficient promotion of the program; b) insufficient col-
laboration between pharmacists and physicians; c) difficul-
ties in integrating the program into the routine activity of
the pharmacy; and d) lack of motivation among pharma-
cists. In 2014, at the request of an infectious disease phys-
ician and a nurse, a project was launched to implement
the IMAP at the public hospital ‘Hôpital neuchâtelois
Pourtalès’, in collaboration with community pharmacists
in the Neuchâtel area (Switzerland). Compared to the
CHUV, Pourtalès hospital is a non-academic state hospital
with around 190 beds that serves the entire county
(178,434 inhabitants in 2016). The hospital infectious dis-
eases outpatient ward manages about 200 HIV-infected
patients [4].
Implementation research in the field of pharmaceutical
care has become essential to ensure transfer of phar-
macy services in the real world, program effectiveness
and fidelity of the service delivery. Several implementa-
tion frameworks exist in the literature, for example the
Re-AIM (Glasgow [5]), the Consolidated Framework for
Implementation Research (Damschroder [6]), the Proc-
tor Conceptual Model for Implementation Research
(Proctor et al. [7]), and the Exploration, Preparation,
Implementation, Sustainment Model (Aarons et al. [8]).
They are, however, not specific to pharmaceutical care
interventions.
In 2015, a new implementation framework specifically
designed for community pharmacists emerged in the litera-
ture. This was the Framework for the Implementation of
Services in Pharmacies (FISpH) developed by Moullin et al.
[9]. The FISpH was based on a literature review of existing
frameworks, from which a qualitative study was conducted
to contextualize and advance the concept framework devel-
oped for pharmacy services [10, 11]. The framework states
that implementation is a complex multi-stage process in-
volving an innovation, a multi-level context (individuals,
pharmacy(s), local setting and system), influenced by a
range of factors, strategies, and evaluations [9].
In Switzerland and worldwide, implementation studies
are scarce and new pharmaceutical services encounter
difficulties to be implemented in community pharma-
cies, hence inhibiting their uptake [10, 12]. Implementa-
tion science is developing and there is a need for data in
the field of community pharmacy services, particularly
concerning implementation processes and used strat-
egies [12]. Therefore, this article aims to describe, the
different stages and the implementation strategies devel-
oped to implement the IMAP in a new clinical setting
using the FISpH.
Method
Study design
This is a descriptive, observational study, focusing on the
a posteriori description of the implementation process to
conceptualize strategies and stages used during the study,
using the FISpH framework [10]. In this project, the re-
search team was involved in both the development of
strategies to support the implementation process and in
the prospective observation of the implementation results.
Quantitative and qualitative results of the prospective ob-
servational study for this implementation project will be
described separately in another article.
Framework used for describing the implementation
process
The FISpH framework was chosen because its develop-
ment emerged from a thorough review of the existing
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literature was adapted in a unique way for community
pharmacy services [10]. It divides the implementation
process into five stages: exploration, preparation, testing,
operation, and sustainability. These stages are preceded
by development of the innovation and by communica-
tion about it.
Described stages
In this paper, the context and strategies have been inves-
tigated in relation to four FISpH stages out of the five:
1) exploration (whereby the end users appraise the
innovation and decide to either accept/adopt or reject
it); 2) preparation (the course of preparation prior to
innovation use), 3) operation (innovative use of services
and their process of being integrated into routine prac-
tice through active and planned approaches), and 4) sus-
tainability (process of maintaining the innovation that
has been integrated as routine practice through contin-
ued innovation, ongoing capacity and supportive envir-
onment, and persistence of innovation benefits) [10].
The testing phase, which in this project could be consid-
ered as the inclusion of the first patients, is not de-
scribed because no real transition from the testing to the
operation phase was planned.
The dissemination of the program, defined as the “ac-
tive approach using planned strategies via determined
channels to persuade the target audience to adopt new
innovations” [10], is part of the communication. This is
described in both the preparation stage and the last
stage of this project. Hence, communication strategies
allow each new professional who wishes to adopt the
intervention to enter a new implementation cycle at the
exploration stage, and then to implement it at his or her
individual level.
Description of the implemented intervention
The IMAP medication adherence program was initially
developed at the community pharmacy center of the
PMU. In 2004, the program became a routine pharmacy
intervention when the collaboration with the infectious
diseases service of the Lausanne University Hospital
(CHUV) was launched. The program aims to support
and to reinforce medication adherence through multifac-
torial and interprofessional intervention. Motivational
interviewing is combined with medication adherence
electronic monitoring and feedback to the patient
(MEMS™ monitors, Aardex MWV, Switzerland), while
the core content of the pharmacist’s intervention is
reported to the patient’s physician and nurse.
Patient-pharmacist interviews last approximately 15 min.
They are repeated over time according to the patient’s
needs [1]. The intervention is based on socio-cognitive
theory, especially the information-motivation-behavior
skills model [13]. The program and its development have
been fully described elsewhere [1].
SISPha, a Swiss startup active in the development of
interprofessional programs dedicated to chronic care
management, scaled up the IMAP. SISPha trains com-
munity pharmacists and pharmacy teams. It developed
an interprofessional web platform for collecting patients’
data related to medication adherence [14]. In the
French-speaking part of Switzerland, all pharmacies can
subscribe to the SISPHA program, be trained in it and
receive a toolbox to support their patients’ medication
adherence. In Switzerland, community pharmacist activ-
ity to support medication adherence in chronic patients
who are prescribed at least three concomitant chronic
drugs are reimbursed by a fee defined by the Swiss
healthcare system [1].
Results
Figure 1 summarizes the timeline and important mile-
stones that drove the project forward across the imple-
mentation stages.
Exploration
In 2014, the attending infectious disease physician
(named physician in the manuscript) and a nurse work-
ing together in the district hospital Hôpital neuchâtelois,
Pourtalès (Neuchâtel, Switzerland) contacted the PMU
community pharmacy center. Both professionals were
confronted with non-adherent patients in their practice
and expressed their willingness to implement the IMAP
in their hospital with the collaboration of community
pharmacists in Neuchâtel (Switzerland).
When the project was launched, five community phar-
macies in Neuchâtel had already decided to adopt the
practice innovation supported by SISPha and were ready
to deliver the program. Unlike the PMU community
pharmacy center, these pharmacies are not affiliated to a
research or academic structure.
Preparation
Key stakeholders were identified and engaged in the im-
plementation of the project from its early stage. These
were a physician, a nurse, five pharmacists and SISPha
collaborators.
SISPha training courses are described in Table 1. They
are not mandatory to deliver the program. However, all
five pharmacists had at least followed the two-day initial
course “Medication adherence program: first steps at the
pharmacy – parts 1 & 2” and received the in-situ train-
ing at the pharmacy before or during the project. One
pharmacist attended all available courses.
Before launching the program, different preparatory
strategies were developed to inform all community phar-
macists in the Neuchâtel area and physicians at the
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Fig. 1 Summary of the important milestones during the implementation process of the IMAP for HIV patients across the implementation stages
of the FISpH framework [12]. This figure describes all important events and strategies developed to implement the IMAP at the hospital and in
community pharmacies. Events are enumerated on a timeline and separated by dotted lines on the basis of the implementation stages
Table 1 Description of SISPha training courses and pharmacist participation during the preparation stage
Title Course objective Who can attend
the course?
Course
duration
Number of trained
pharmaciesa
Medication adherence program: first steps at
the pharmacy (part 1)
Understanding medication adherence and related
issues – defining and developing strategies to
implement the program in the pharmacy setting
Pharmacists 1 day 5/5
Medication adherence program: first steps at
the pharmacy (part 2)
Building up competencies in presenting the program
to patients and physicians
Pharmacists 1 day 5/5
The medication adherence interview Initiation in motivational interviewing; learning about
available tools for monitoring and supporting
medication adherence
Pharmacists 2 days 3/5
Proposal and follow-up interviews Building up competencies in engaging patients in the
program and in conducting medication adherence
interviews
Pharmacists 1 day 1/5
What is the role of the pharmacy
technician?
Training in uploading and managing EMb data on
SISPha web platform
Pharmacy
technicians
4 h 0/5
A team story In-situ entire team training at the pharmacy Pharmacy team 2 h30 5/5
aAmong the pharmacies involved in the project (n = 5)
bEM electronic monitor
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hospital about the project and to prepare the necessary
documentation (Table 2 and Fig. 1). To start the oper-
ation stage officially and to develop an interprofessional
collaboration, a kickoff meeting between the physician,
the nurse, the five pharmacists, SISPha and the research
team was organized.
Operation
The IMAP started in Neuchâtel in November 2014
(Fig. 1). The roles of each stakeholder are described
in Table 3.
During this stage, it was decided to organize meetings
every six months between all involved stakeholders.
These meetings were held to discuss the implementation
progress and each stakeholder’s expectations, and to ex-
change experiences to facilitate the interprofessional col-
laboration and the program delivery. As the PMU
research team was also involved in these sessions, it was
an opportunity to exchange experiences and share the
IMAP guidelines as implemented at the PMU. The con-
tent of these meetings was adapted according to the im-
plementation progress and the healthcare professionals’
feedback and needs. Each issue detected during the dis-
cussion was addressed and then reviewed during the
next meeting. The research team also supported the
physician and the nurse in the patient inclusion process
through a monthly teleconference with the nurse to
evaluate the inclusion process and related issues.
The nurse spontaneously took the lead at the hospital.
She identified eligible patients with the physician and
was in charge of the administrative work related to the
project. A structural organizational change in the hos-
pital lengthened the stay of the ward’s visiting intern, an
infectious disease fellow, to six months. This allowed the
physician and the nurse to include the intern in the pro-
gram. To do so, the nurse developed local procedures
and started to train the new intern. Analysis of the pro-
ject by the research team found that this improvement
was the pivotal event in the transition between the oper-
ation and the sustainability stages. Among the pharma-
cists, only one pharmacist reorganized internal activity,
which she did upon the arrival of a new pharmacist dur-
ing the project. This team organization allowed the par-
ticipating pharmacist to enter a routinization phase and
then to move to the sustainability stage.
Sustainability
During the sustainability phase, the nurse and the phys-
ician extended the program to hepatitis C patients. A
fourth meeting with all stakeholders was organized two
years after the first patient was included to discuss the sus-
tainability of the program. To reinforce this sustainability,
the healthcare professional team decided to hold an
Table 2 Description of the strategies developed during the preparation stage of the IMAP implementation
Interventions Provision level Developed strategies
Dissemination of the project Local setting (pharmacies) Identification of trained community pharmacists and encouragement of new
pharmacists to receive training in medication adherence (e.g. SISPha program)
Local setting (hospital) Presentation of the medication adherence program to inform all healthcare
professionals (physicians and nurses) at the local hospital
Development of the documentation
by the research team
Organization (hospital) “Descriptive document of the program” for the physician and the nurse to help
them present the program to patients, including the list of trained pharmacists
Organization (hospital) A check-list for the physician and the nurse for collecting patient inclusion data.
Collected data were: 1) proposal date; 2) acceptation or refusal of inclusion; 3)
reason for proposal; 4) reason for refusal or chosen pharmacy for the program,
whichever applies
Organization (research) The study protocol elaborated by the research team to evaluate the
implementation outcomes; this was reviewed and approved by the physician,
the nurse and SISPha
Development of the interprofessional
collaboration
Organization (pharmacists,
physician, nurse, SISPha,
research team)
Organization of a kickoff meeting between all stakeholders to discuss and align
the expectations of all stakeholders, and to present the study protocol
Table 3 Respective roles of each involved stakeholder during the operation stage of the IMAP implementation process
Stakeholders Roles
The physician and the nurse Include patients in the program and refer them to a pharmacist, who delivers the IMAP
Pharmacists Deliver the IMAP and send the medication adherence report to the physician and the nurse
SISPha Train pharmacists and provide the necessary tools (web platform and electronic monitors)
The research team Organize regular meetings with stakeholders, support the implementation process and
establish the collaboration between the pharmacists and the physician-nurse dyad
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interprofessional meeting at the hospital each semester, to
be organized alternately by the nurse and one pharmacist.
Here, the pharmacists would present one or two complex
clinical cases. These cases would be discussed with the
physician and the nurse to agree on an interprofessional
follow-up of the patient. The first interprofessional meeting
– without the research team – took place in November
2017. Two physicians, one nurse and four pharmacists
took part.
Dissemination
The program and the first results of the implementation
study were presented to the board of the local pharma-
cists’ association (Ordre Neuchâtelois des Pharmaciens –
ONP) two years after the first patient was included. This
meeting was organized to promote the project and en-
courage more pharmacists to provide the IMAP in their
practice. A letter summarizing the implementation re-
sults was sent to all pharmacists in the Neuchâtel area
through the ONP. At the hospital, the research team
presented the results of this project to the general prac-
titioners in the Neuchâtel area at a conference in order
to enhance the program’s adoption.
Discussion
This project aimed to implement the IMAP in the infec-
tious diseases department of the local hospital of Neu-
châtel area with the collaboration of community
pharmacists. The experience of the PMU community
pharmacy with the IMAP program, the involvement of
the PMU research team – who supported and evaluated
the implementation process – and the collaboration with
SISPha – who trained and supported the pharmacists –
were essential to launch and push the implementation
project forward. Two important strategies allowed stake-
holders to move the project forward: 1) regular meetings
between stakeholders to develop interprofessional col-
laboration and teamwork; and 2) the formalization of
the activity at the hospital and in one pharmacy through
the involvement of new colleagues, made possible thanks
to structural changes (e.g. the infectious disease fellow’s
six-month internship). Importantly, our results also
show that such a process takes time as two years were
needed to reach structural changes.
In the literature, different strategies are described to
facilitate the implementation of new services. Powell et
al. published a compilation of 75 implementation strat-
egies [15]. Some of these were used during the prepar-
ation stage of our IMAP implementation: 1) develop an
academic partnership; 2) assess for readiness and identify
barriers and facilitators; 3) conduct education meetings;
and 4) develop and organize quality monitoring. Other
strategies were used during the operation and sustain-
ability stages of the IMAP implementation: 1) build a
coalition (recruit and cultivate relationships with part-
ners in the implementation effort); 2) provide feedback
in implementation team meetings; and 3) remind clini-
cians to deliver the medication adherence program. Ac-
cording to the Watkins et al. study, the most effective
strategies for implementing clinical guidelines in com-
munity pharmacies are educational interventions and
computerized decision support [16]. In this project, the
courses and the web software developed by SISPha
helped pharmacists implement the program in their
pharmacies. However, based on our observations, the
most useful strategy to develop interprofessional collab-
oration, exchange experiences and align expectations,
and give feedback on the implementation progress was
the organization of regular meetings with all stake-
holders. These meetings helped to create a positive at-
mosphere and nurture the climate for change. The
implementation climate is defined by Klein and Sorra as
“the extent to which intended users perceive that
innovation use is expected, supported, and rewarded”
[17]. In our program, the future challenge for the in-
volved healthcare professionals is to maintain the estab-
lished dynamic.
Sustainability is the least described stage in the litera-
ture and many projects have failed to continue to deliver
a new intervention on the long term [18]. In Neuchâtel,
the sustainability stage was reached, and the project con-
tinued to be delivered after the end of the study. The
two-year support provided by the research team was es-
sential for this project and generated information about
the program’s sustainability. This support is not feasible
in the long run and was therefore transferred to the
healthcare professionals. Long-term monitoring, without
research support, has been put in place by the research
team to assess the capacity of healthcare professionals to
maintain the program in their practice.
This project had several limits. First, the project
started exclusively with innovators as it included only
one physician, one intern, one nurse and five pharma-
cists. It will be important to monitor the uptake of the
project by other pharmacists, physicians and nurses. An-
other limit was that the transition between the testing
and the operation stages was not clearly defined and
thus not described in this paper. A clear definition and
the evaluation of a testing stage could bring additional
information and could improve the implementation pro-
gress by overcoming barriers detected during this stage.
However, we used the results of an unsuccessful imple-
mentation study that we carried out in the past as a test-
ing phase [3]. The four barriers that emerged from this
former experience were removed by the active collabor-
ation of all stakeholders and the proposed medication
adherence training for pharmacists. Moreover, the
organization of regular meetings allowed the research
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team to assess and overcome barriers in a timely and ef-
ficient way. In the future, the feasibility of these regular
meetings should be investigated on a larger scale. The
dissemination of the IMAP to a larger scale started with
the communication of the information to other health-
care professionals and by addressing another pathology
than solely HIV (i.e. hepatitis C). A larger study is cur-
rently being supported by the national government in
Switzerland to implement an integrated chronic care
management model combining the IMAP with the treat-
ment plan reconciliation in patients with diabetes type 2
[19]. This study should bring more results on IMAP im-
plementation in daily routine. Pharmacists involved in
the HIV IMAP implementation project also started this
new study in diabetes.
Conclusion
The transfer of the IMAP for HIV patients to a
non-academic setting and its implementation are feas-
ible. The implementation of a new model of pharmacy
service such as IMAP implies a deep change in practice,
e.g. organizational changes, development of communica-
tion between healthcare professionals, and changes in
mentalities. Moreover, the medium-term external
support of an implementation research team and the al-
location of sufficient resources are essential for the
long-term sustainability of such a project.
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